EW's first-quarter 2025 performance is likely to have gained from growth drivers across its businesses amid macroeconomic headwinds. IRVINE, Calif., April 16, 2025--Edwards Lifesciences (NYSE ...

Wall Street analysts expect Edwards Lifesciences (EW) to post quarterly earnings of $0.60 per share in its upcoming report, which indicates a year-over-year decline of 9.1%. Revenues are expected to ...